Ophthalmic composition for dry eye therapy
Disclosed in embodiments are gel formulations which are not subject to the settling out phenomena that may be observed with Loteprednol etabonate suspensions.
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Disclosed in embodiments are gel formulations which are not subject to the settling out phenomena that may be observed with Loteprednol etabonate suspensions. |
---|